However, it is noteworthy, that although the (CK+/JUNB–/CXCR4–) phenotype was the most frequent in SCLC, none of the patients nor their CTCs had exclusively that phenotype, which was also the case in breast cancer DTCs [19]. This evidence concerns the gene CXCR4 and breast carcinoma.